PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...
Irish Examiner on MSN14h
I was shocked to be diagnosed with triple-negative breast cancer in my 40sCiara Foskin’s diagnosis came out of the blue. She is part of a small cohort of women under 50 who develop triple-negative ...
DelveInsight's "VERZENIO Market Size, Forecast, and Market Insight Report" highlights the details around VERZENIO, which is a ...
As genetic and biomarker tests become more common, so do new therapies that target specific tumor types and may lead to ...
It would be short-sided, erroneous and dangerous to think ill of mifepristone, which has several important applications,, M.D ...
Triple-positive breast cancer is a type of breast cancer that tests positive for estrogen receptors, progesterone receptors, and high levels of HER2 protein. Some types of breast cancer cells use ...
hypokalemia or QT prolongation – serious adverse events that can arise in patients taking currently approved medications – ...
Corcept Therapeutics (CORT) announced that the FDA filed its New Drug Application (NDA) submission for its proprietary, selective cortisol ...
An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback